According to the NCI website, the LSD1 inhibitor CC-90011 is an orally available inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity. Check for active clinical trials using this agent. (NCI Thesaurus)

More Information in English:

AdisInsight
Link to National Cancer Institute